Status:
RECRUITING
Drug Management in Heart Failure
Lead Sponsor:
IRCCS San Raffaele Roma
Collaborating Sponsors:
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts...
Detailed Description
Heart Failure (HF) is a worldwide leading cause of death and continues to increase, with important implications for healthcare providers. International guidelines (GGLL) for patients with HF recommend...
Eligibility Criteria
Inclusion
- Both gender
- Age \>18 years
- Signed informed consent for the study
- Known diagnosis of heart failure \> 6 months
- Recent or ongoing hospitalization for heart failure exacerbation
Exclusion
- Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons
- Concurrent diagnosis of neoplasia
- Advanced COPD (FEV1 \<50%)
- Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)
Key Trial Info
Start Date :
November 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06915584
Start Date
November 30 2024
End Date
August 31 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCs San Raffaele
Rome, RM, Italy, 00166